These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 10571771)

  • 41. Proximal tubular cells promote fibrogenesis by TGF-beta1-mediated induction of peritubular myofibroblasts.
    Abbate M; Zoja C; Rottoli D; Corna D; Tomasoni S; Remuzzi G
    Kidney Int; 2002 Jun; 61(6):2066-77. PubMed ID: 12028447
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Automated image analysis of a glomerular injury marker desmin in spontaneously diabetic Torii rats treated with losartan.
    Kakimoto T; Okada K; Hirohashi Y; Relator R; Kawai M; Iguchi T; Fujitaka K; Nishio M; Kato T; Fukunari A; Utsumi H
    J Endocrinol; 2014 Jul; 222(1):43-51. PubMed ID: 24781258
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
    Okada M; Takemura T; Yanagida H; Yoshioka K
    Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diabetic nephropathy: the central role of renal proximal tubular cells in tubulointerstitial injury.
    Phillips AO; Steadman R
    Histol Histopathol; 2002 Jan; 17(1):247-52. PubMed ID: 11813875
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Superior renoprotective effects of the combination of breviscapine with enalapril and its mechanism in diabetic rats.
    Xu XX; Zhang W; Zhang P; Qi XM; Wu YG; Shen JJ
    Phytomedicine; 2013 Jul; 20(10):820-7. PubMed ID: 23664882
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Can we target tubular damage to prevent renal function decline in diabetes?
    Bonventre JV
    Semin Nephrol; 2012 Sep; 32(5):452-62. PubMed ID: 23062986
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renal tubular basement membrane and collagen type IV in diabetes mellitus.
    Ziyadeh FN
    Kidney Int; 1993 Jan; 43(1):114-20. PubMed ID: 8433550
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nox4 and diabetic nephropathy: with a friend like this, who needs enemies?
    Gorin Y; Block K
    Free Radic Biol Med; 2013 Aug; 61():130-42. PubMed ID: 23528476
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathophysiologic glomerulotubular growth factor link.
    Wang SN; LaPage J; Hirschberg R
    Miner Electrolyte Metab; 1999; 25(4-6):234-41. PubMed ID: 10681646
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanisms of disease: the hypoxic tubular hypothesis of diabetic nephropathy.
    Singh DK; Winocour P; Farrington K
    Nat Clin Pract Nephrol; 2008 Apr; 4(4):216-26. PubMed ID: 18268525
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New developments concerning the proximal tubule in diabetic nephropathy: in vitro models and mechanisms.
    Slyne J; Slattery C; McMorrow T; Ryan MP
    Nephrol Dial Transplant; 2015 Aug; 30 Suppl 4():iv60-7. PubMed ID: 26209740
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The localisation of sorbitol pathway activity in the rat renal cortex and its relationship to the pathogenesis of the renal complications of diabetes mellitus.
    Hutton JC; Schofield PJ; Williams JF; Hollows FC
    Aust J Exp Biol Med Sci; 1975 Feb; 53(1):49-57. PubMed ID: 125079
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tubular changes in early diabetic nephropathy.
    Thomas MC; Burns WC; Cooper ME
    Adv Chronic Kidney Dis; 2005 Apr; 12(2):177-86. PubMed ID: 15822053
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diabetic nephropathy: the modulating influence of glucose on transforming factor beta production.
    Phillips AO
    Histol Histopathol; 1998 Apr; 13(2):565-74. PubMed ID: 9589909
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extracellular matrix metabolism in diabetic nephropathy.
    Mason RM; Wahab NA
    J Am Soc Nephrol; 2003 May; 14(5):1358-73. PubMed ID: 12707406
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New insights into the mechanisms of fibrosis and sclerosis in diabetic nephropathy.
    Brosius FC
    Rev Endocr Metab Disord; 2008 Dec; 9(4):245-54. PubMed ID: 18726161
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Imaging mass spectrometry reveals direct albumin fragmentation within the diabetic kidney.
    Grove KJ; Lareau NM; Voziyan PA; Zeng F; Harris RC; Hudson BG; Caprioli RM
    Kidney Int; 2018 Aug; 94(2):292-302. PubMed ID: 29779708
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diabetic nephropathy: mechanisms of renal disease progression.
    Kanwar YS; Wada J; Sun L; Xie P; Wallner EI; Chen S; Chugh S; Danesh FR
    Exp Biol Med (Maywood); 2008 Jan; 233(1):4-11. PubMed ID: 18156300
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A glimpse of various pathogenetic mechanisms of diabetic nephropathy.
    Kanwar YS; Sun L; Xie P; Liu FY; Chen S
    Annu Rev Pathol; 2011; 6():395-423. PubMed ID: 21261520
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CHOP-ASO Ameliorates Glomerular and Tubular Damage on Top of ACE Inhibition in Diabetic Kidney Disease.
    Shahzad K; Fatima S; Al-Dabet MM; Gadi I; Khawaja H; Ambreen S; Elwakiel A; Klöting N; Blüher M; Nawroth PP; Mertens PR; Michel S; Jaschinski F; Klar R; Isermann B
    J Am Soc Nephrol; 2021 Dec; 32(12):3066-3079. PubMed ID: 34479965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.